Our Pricing

Comparing Mysimba vs Ozempic: Which Weight Loss Treatment Works for You?

Published on: June 03, 2026

Choosing between mysimba vs ozempic online prescription uk options requires understanding how each medication works and which suits your lifestyle. At Cured Pharmacy, our UK-registered prescribers assess your medical history to recommend the most appropriate treatment, whether that's oral tablets or weekly injections.

Mysimba vs Ozempic: How They Work Differently

Mysimba (naltrexone/bupropion) is an oral tablet combining two active ingredients that work on the central nervous system to reduce appetite and food cravings [1]. Unlike injectable treatments, Mysimba targets reward pathways in the brain, making it particularly effective for patients whose weight gain relates to emotional eating or cravings.

Ozempic (semaglutide) is a GLP-1 receptor agonist administered as a weekly injection. It mimics a natural gut hormone that regulates blood sugar and slows gastric emptying, creating prolonged fullness after meals [2]. Clinical trials show semaglutide can support average weight reductions of 15-17% over 68 weeks when combined with lifestyle changes [2].

The fundamental difference lies in delivery method and mechanism: Mysimba requires daily oral dosing and works centrally on appetite control, whilst Ozempic involves weekly injections and acts peripherally on digestion and satiety hormones. Neither medication is inherently superior — suitability depends on your medical history, injection tolerance, and treatment preferences.

Mysimba Tablets: Who Benefits Most

Mysimba tablets contain 8mg naltrexone and 90mg bupropion per tablet, taken twice daily after titration [1]. The naltrexone component, traditionally used for addiction treatment, blocks opioid receptors involved in reward-driven eating. Bupropion, an antidepressant, modulates dopamine and noradrenaline to reduce hunger signals.

Clinical data from the COR trials demonstrated patients taking Mysimba achieved average weight loss of 5-10% over 56 weeks when combined with reduced-calorie diets [1]. Response rates vary significantly — approximately 50% of patients achieve clinically meaningful weight loss (≥5% body weight), whilst others may see minimal benefit.

Mysimba suits patients who prefer oral medication, have contraindications to GLP-1 treatments, or struggle primarily with cravings rather than portion control. It's particularly relevant for those with binge-eating tendencies or emotional eating patterns.

Mysimba Contraindications and Cautions

Mysimba is contraindicated in patients with uncontrolled hypertension, seizure disorders, eating disorders, or those taking opioid medications [1]. The bupropion component carries a small seizure risk (approximately 0.1% at recommended doses), necessitating careful patient selection. Your UK prescriber will review your complete medication list and medical history before approval, as interactions with MAO inhibitors and certain antidepressants can be serious.

Ozempic for Weight Loss: Clinical Evidence

Whilst Ozempic is primarily licensed for type 2 diabetes management in the UK, its active ingredient semaglutide is also available as Wegovy, specifically licensed for weight management [2]. Both contain identical active ingredients at different dose ranges — Ozempic reaches 1mg weekly, whilst Wegovy escalates to 2.4mg.

The STEP clinical trial programme demonstrated semaglutide 2.4mg produced average body weight reductions of 15.3% over 68 weeks, compared to 2.6% with placebo [2]. Participants reported sustained appetite suppression and early satiety, with gastrointestinal side effects (nausea, diarrhoea) being the most common treatment-related events.

For weight loss specifically, UK prescribers typically recommend Wegovy over Ozempic due to the higher licensed dose range and specific weight management indication. However, supply constraints occasionally make Ozempic a considered alternative for appropriate patients, subject to prescriber discretion and MHRA guidance.

Who Should Consider GLP-1 Treatments

GLP-1 receptor agonists like semaglutide suit patients comfortable with weekly self-injection, those with co-existing type 2 diabetes, or individuals who haven't responded adequately to oral weight loss medications. They're particularly effective for patients whose primary challenge is portion control rather than cravings. Contraindications include personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome type 2 [2].

Mysimba vs Ozempic: Side Effect Profiles

Mysimba's most frequently reported side effects include nausea (occurring in approximately 30% of patients), headache, constipation, dizziness, and insomnia [1]. These typically emerge during dose titration and often diminish with continued use. Blood pressure monitoring is essential, as some patients experience increases requiring treatment adjustment or discontinuation.

Ozempic and other semaglutide formulations commonly cause gastrointestinal effects — nausea affects 20-44% of patients, particularly during dose escalation [2]. Vomiting, diarrhoea, and constipation are also frequent. These effects usually improve after 4-8 weeks as the body adapts. Rare but serious risks include pancreatitis and gallbladder disease, necessitating prompt medical attention if severe abdominal pain develops.

The side effect experience differs substantially between treatments. Mysimba's central nervous system effects (headache, insomnia, dizziness) contrast with semaglutide's predominantly gastrointestinal profile. Neither medication is universally better tolerated — individual response varies considerably, and your prescriber will consider your tolerance history when recommending treatment.

Cost Comparison: Mysimba vs Ozempic Online Prescription UK

At Cured Pharmacy, Mysimba tablets start from £135.00 for a month's supply, making it a competitive option compared to typical UK market rates. Pricing includes the medication, UK prescriber consultation, and discreet delivery to your address. Unlike some services, we display prices upfront before you begin your consultation, ensuring complete transparency.

Injectable GLP-1 treatments vary in cost depending on the specific medication and dose. Our weight loss range includes multiple options at different price points, all requiring the same clinical assessment process. Every prescription medication at Cured Pharmacy undergoes review by our UK-registered clinical team, ensuring appropriate, safe prescribing regardless of treatment choice.

When comparing costs, consider the complete treatment picture: Mysimba requires twice-daily dosing with ongoing monthly refills, whilst weekly injections involve less frequent administration but require injection supplies. Neither approach is inherently more economical — total cost depends on treatment duration, dose adjustments, and individual response rates.

Transparent Pricing at Cured Pharmacy

We guarantee the lowest prices in the UK for genuine, MHRA-licensed medications. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every prescription meets rigorous safety standards whilst maintaining competitive pricing. All costs are displayed before consultation, with no hidden fees or surprise charges at checkout.

Getting Your Mysimba vs Ozempic Online Prescription UK

Accessing prescription weight loss treatment through Cured Pharmacy takes under three minutes. Our online consultation captures your medical history, current medications, and weight loss goals. UK-registered prescribers review every submission individually — this isn't an automated approval system, but genuine clinical assessment ensuring treatment safety and appropriateness.

If approved, your prescription is dispensed from our GPhC-registered pharmacy (registration 9012511) and dispatched in 100% discreet packaging. We stock genuine UK-licensed medications only — no grey imports or unlicensed formulations. Delivery timescales depend on your location and chosen service, with tracking provided for all orders.

Not every applicant will be approved for their requested medication. Contraindications, medication interactions, or insufficient clinical indication may result in alternative recommendations or treatment decline. This protective approach reflects our commitment to safe, responsible prescribing rather than simply processing orders. Your health outcomes matter more than transaction volume.

Ongoing Support and Monitoring

Weight loss medication requires ongoing monitoring to assess efficacy, manage side effects, and adjust doses appropriately. Our clinical team remains available throughout your treatment journey via phone (+44 116 4646009) or online messaging. Regular follow-up consultations ensure your treatment remains safe and effective, with dose adjustments made as clinically indicated. This continuity of care distinguishes pharmacy-led services from one-off prescription mills.

Scientific References

1. Greenway, F. L., et al. (2010). Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 376(9741), 595–605. https://doi.org/10.1016/S0140-6736(10)60888-4 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Davies, M., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
4. Medicines and Healthcare products Regulatory Agency. (2023). Mysimba 8 mg/90 mg prolonged-release tablets - Summary of Product Characteristics. GOV.UK. https://products.mhra.gov.uk/ [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to prescribed treatment alongside appropriate diet and exercise modifications.